RAA-CRISPR/Cas12a-中介的快速,灵敏和现场检测在子中发现纽卡斯尔病
Libin Liang1, Dou Wang1, Zhen Gao1
1College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China.
Veterinary sciences
|October 25, 2024
概括
使用复合酶辅助放大 (RAA) 和CRISPR/Cas12a的新诊断方法可以快速,准确地在现场检测子纽卡斯尔病 (PPMV-1). 这种RAA-CRISPR/Cas12a-LFD方法有助于及时控制这种重要的禽病原体.
科学领域:
- 兽医病毒学 兽医病毒学
- 分子诊断学 分子诊断
- 鸟类传染病 鸟类传染病
背景情况:
- 子新冠病毒1型 (PPMV-1) 引起的子新冠病毒导致高死亡率,并威胁着子产业.
- 快速准确的现场诊断对于有效的疾病管理和控制至关重要.
研究的目的:
- 为PPMV-1建立一个快速,具体和敏感的现场诊断方法.
- 开发一种结合复合酶辅助放大 (RAA) 和CRISPR/Cas12a技术的检测系统.
主要方法:
- 开发了RAA原始剂,准保存的L基因区域,用于PPMV-1的预放大.
- 使用CRISPR/Cas12a进行目标基因检测,用侧向流量测量棒 (LFD) 可视化.
- 使用临床子样本验证了该方法,并将灵敏度与定量实时PCR进行了比较.
主要成果:
- 该RAA-CRISPR/Cas12a-LFD方法显示高特异性,没有与非PPMV-1样本的交叉反应.
- 灵敏度达到了10^0副本/μL (光) 和10^3副本/μL (LFD).
- 临床样本测试显示了快速和准确的检测,与定量实时PCR相一致.
结论:
- 开发的RAA-CRISPR/Cas12a-LFD方法为快速,简单,精确和特定的子纽卡斯尔病现场诊断提供了一种新方法.
- 这项技术有助于及时干预和控制受影响群的疾病.
相关概念视频
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
01:28CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...